NCT00818753 - Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

August 31, 2010

Conditions

Heart Catheterization

Interventions

DRUG

dabigatran 110 mg

comparison of different dabigatran dosages with unfractionated heparin

DRUG

dabigatran 150 mg

comparison of different dabigatran dosages with unfractionated heparin

DRUG

unfractionated heparin

comparison of different dosages dabigatran with unfractionated heparin

Trial Locations (4)

1160.73.31004 Boehringer Ingelheim Investigational Site, Alkmaar

1160.73.31003 Boehringer Ingelheim Investigational Site, Nieuwegein

1160.73.1 Boehringer Ingelheim Investigational Site, Rotterdam

1160.73.31002 Boehringer Ingelheim Investigational Site, Rotterdam